💊 Benzodiazepines

Benzodiazepines are a class of psychoactive drugs that are central nervous system depressants. They are primarily used for their anxiolytic, sedative, hypnotic, muscle relaxant, and anticonvulsant properties.

Benzodiazepines enhance the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor. They bind to a specific allosteric site on the GABA-A receptor, increasing the frequency of chloride channel opening. This leads to an influx of chloride ions, hyperpolarising the neuron and reducing neuronal excitability.

Benzodiazepines are indicated for the short-term management of severe anxiety, insomnia (when severe, disabling, or causing extreme distress), and acute alcohol withdrawal. They are also used for status epilepticus and as pre-medication for surgical or diagnostic procedures. Long-term use is generally discouraged due to dependence risk.

Contraindications include acute narrow-angle glaucoma, myasthenia gravis, severe respiratory insufficiency, and sleep apnoea syndrome. They should be used with extreme caution in patients with a history of substance abuse, severe hepatic impairment, and in the elderly due to increased sensitivity and risk of falls.

Common adverse effects include sedation, drowsiness, dizziness, ataxia, and cognitive impairment. Paradoxical effects such as increased anxiety, agitation, and aggression can occur. Long-term use carries a significant risk of tolerance, dependence, and withdrawal symptoms upon cessation, which can be severe and life-threatening.

Monitoring is primarily clinical, focusing on the patient's response to treatment and any signs of adverse effects like excessive sedation or paradoxical reactions. For long-term use, regular assessment for tolerance and dependence is crucial. Respiratory rate and oxygen saturation may be monitored in acute overdose or in patients with respiratory compromise.

When prescribing, always check for allergies and carefully assess the patient's history of substance abuse. Be highly cautious of interactions with other CNS depressants, such as opioids and alcohol, due to increased risk of respiratory depression. Counselling must emphasise short-term use, the risk of dependence, and the importance of gradual dose reduction when discontinuing.

High-yield topics include the short-term nature of benzodiazepine prescribing and the significant risks of tolerance, dependence, and withdrawal. Recognition of benzodiazepine overdose symptoms and their management (e.g., flumazenil) is important. Their role in acute alcohol withdrawal and seizure management is also frequently tested.

SBAs frequently test the risks of dependence and withdrawal symptoms associated with benzodiazepines, particularly in the context of long-term use. Questions may also focus on their use in acute alcohol withdrawal and status epilepticus. Understanding the dangers of co-prescribing with other CNS depressants is a common theme.